Tammenoms Juliet Bakker's Insider Trades & SAST Disclosures
Tammenoms Juliet Bakker's most recent trade in Ceribell Inc. was a trade of 2,140,600 Series C-1 Preferred Stock done . Disclosure was reported to the exchange on Oct. 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Tammenoms Juliet Bakker.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ceribell Inc. | Tammenoms Juliet Bakker | Director | 11 Oct 2024 | 2,140,600 | 0 | - | - | Series C-1 Preferred Stock | ||
| Ceribell Inc. | Tammenoms Bakker Juliet | Director | 11 Oct 2024 | 2,140,600 | 2,237,876 | - | - | Common Stock | ||
| Ceribell Inc. | Bakker Juliet Tammenoms | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 11 Oct 2024 | 237,234 | 2,475,110 | - | 17 | 4,032,978 | Common Stock |
| Ceribell Inc. | Juliet Tammenoms Bakker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2024 | 6,618 | 6,618 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 2,554 | 37,394 | - | - | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Purchase of securities on an exchange or from another person at price $ 61.09 per share. | 17 May 2024 | 5,000 | 34,840 | - | 61.1 | 305,457 | Common Stock |
| RxSight Inc | Tammenoms Juliet Bakker | Director | Purchase of securities on an exchange or from another person at price $ 50.38 per share. | 12 Feb 2024 | 4,000 | 25,840 | - | 50.4 | 201,520 | Common Stock |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Purchase of securities on an exchange or from another person at price $ 51.29 per share. | 12 Feb 2024 | 4,000 | 29,840 | - | 51.3 | 205,153 | Common Stock |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 24 Aug 2023 | 267,300 | 445,400 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Sale of securities on an exchange or to another person at price $ 29.25 per share. | 24 Aug 2023 | 16,208 | 53,173 | - | 29.3 | 474,129 | Common Stock |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 24 Aug 2023 | 970 | 69,381 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 24 Aug 2023 | 416 | 855 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Sale of securities on an exchange or to another person at price $ 30.06 per share. | 17 Aug 2023 | 18,484 | 83,062 | - | 30.1 | 555,694 | Common Stock |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Sale of securities on an exchange or to another person at price $ 29.07 per share. | 17 Aug 2023 | 14,651 | 68,411 | - | 29.1 | 425,877 | Common Stock |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 09 Aug 2023 | 497,150 | 994,313 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 09 Aug 2023 | 32,950 | 101,546 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 14 Jun 2023 | 267,300 | 712,700 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 14 Jun 2023 | 1,022 | 68,596 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 14 Jun 2023 | 439 | 439 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,731 | 67,574 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 26 May 2023 | 497,150 | 1,491,463 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 26 May 2023 | 33,135 | 61,843 | - | 0 | Common Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Purchase of securities on an exchange or from another person at price $ 12.50 per share. | 10 Feb 2023 | 480,000 | 980,000 | - | 12.5 | 6,000,000 | Common Stock |
| RxSight Inc | Juliet Tammenoms Bakker | Director | 03 Aug 2021 | 1,863,613 | 1,863,613 | - | 0 | Common Stock | ||
| RxSight Inc | Juliet Tammenoms Bakker | Director | 03 Aug 2021 | 1,613,423 | 0 | - | - | Series G Preferred Stock | ||
| RxSight Inc | Juliet Tammenoms Bakker | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 03 Aug 2021 | 500,000 | 500,000 | - | 16 | 8,000,000 | Common Stock |
| RxSight Inc | Juliet Tammenoms Bakker | Director | 03 Aug 2021 | 242,013 | 0 | - | - | Series H Preferred Stock | ||
| RxSight Inc | Juliet Tammenoms Bakker | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 03 Aug 2021 | 125,000 | 1,988,613 | - | 16 | 2,000,000 | Common Stock |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 36,302 | 36,302 | - | - | Series H Preferred Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 36,302 | 0 | - | - | Warrant (right to buy) | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Aug 2021 | 28,125 | 8,177 | - | - | Series H Preferred Stock | |
| RxSight Inc | Juliet Tammenoms Bakker | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 03 Aug 2021 | 12,500 | 18,359 | - | 16 | 200,000 | Common Stock |
| RxSight Inc | Juliet Tammenoms Bakker | Director | 03 Aug 2021 | 8,177 | 0 | - | - | Series H Preferred Stock | ||
| RxSight Inc | Juliet Tammenoms Bakker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 5,859 | 5,859 | - | 0 | Common Stock | |
| Eargo Inc | Juliet Tammenoms Bakker | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 May 2021 | 1,000,000 | 1,918,691 | - | 0 | Common Stock | |
| Eargo Inc | Juliet Tammenoms Bakker | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 May 2021 | 3,508 | 7,016 | - | 0 | Common Stock | |
| Eargo Inc | Juliet Tammenoms Bakker | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 May 2021 | 1,504 | 3,008 | - | 0 | Common Stock | |
| Eargo Inc | Juliet Tammenoms Bakker | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Apr 2021 | 1,000,000 | 2,918,691 | - | 0 | Common Stock | |
| Eargo Inc | Juliet Tammenoms Bakker | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Apr 2021 | 3,508 | 3,508 | - | 0 | Common Stock | |
| Eargo Inc | Juliet Tammenoms Bakker | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Apr 2021 | 1,504 | 1,504 | - | 0 | Common Stock | |
| Eargo Inc | Juliet Tammenoms Bakker | Director, Ten Percent Owner | 20 Oct 2020 | 3,685,358 | 0 | - | - | Series E Preferred Stock | ||
| Eargo Inc | Juliet Tammenoms Bakker | Director, Ten Percent Owner | 20 Oct 2020 | 3,685,358 | 3,685,358 | - | - | Common Stock | ||
| Eargo Inc | Juliet Tammenoms Bakker | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 20 Oct 2020 | 233,333 | 3,918,691 | - | 18 | 4,199,994 | Common Stock |
| Eargo Inc | Juliet Tammenoms Bakker | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2020 | 6,666 | 6,666 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Juliet Tammenoms Bakker | Director | Sale of securities on an exchange or to another person at price $ 42.67 per share. | 18 Sep 2020 | 9,167 | 3,500 (0%) | 0% | 42.7 | 391,119 | Common Stock |
| Axonics Inc | Juliet Tammenoms Bakker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2020 | 3,500 | 12,667 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | Juliet Tammenoms Bakker | Director | Sale of securities on an exchange or to another person at price $ 43.22 per share. | 14 Aug 2020 | 2,393 | 9,167 (0%) | 0% | 43.2 | 103,422 | Common Stock |
| Axonics Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 10 Aug 2020 | 978,000 | 1,955,333 (5%) | 2% | 0 | Common Stock | |
| Axonics Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 10 Aug 2020 | 2,393 | 11,560 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | Juliet Tammenoms Bakker | Director | Other type of transaction at price $ 0.00 per share. | 10 Aug 2020 | 1,026 | 1,026 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges